semaglutide vs tirzepatide vs wegovy Zepbound versus Wegovy: Which one is better? how is tirzepatide different from

Dan Med J

More than half lost over 20%, the level where obesity-related complications improve dramatically

5 Obesity portfolio goes beyond GLP-1 AstraZeneca is building optionality: AZD6234 (long-acting amylin) Phase 2 readout H1 2026 AZD6234 + AZD9550 (GLP-1/glucagon combo) Phase 2 readout H2 2026 $1.2B upfront to CSPC Pharmaceutical Group for ex-China rights to eight programs, led by SYH2082, a once-monthly GLP-1R/GIPR agonist My takeaway Withholding data is risky but moving into Phase 3 is louder than any slide

Dziki innowacyjnemu mechanizmowi dziaania, otwiera nowe moliwoci w terapii cukrzycy typu 2 i otyoci

Brambilla P, Crin A, Bedogni G, Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology (ISPED), et al